Epigenetics Market Latest Innovations, Future Scope and Market Trends

1
Epigenetics Market Global Analysis and Forecast
to 2028

• Published Date Jan 2019

Email sales_at_theinsightpartners.com
2
Report Studies
Email sales_at_theinsightpartners.com

• Epigenetics Market Forecast to 2025 COVID-19
  Impact and Global Analysis by Product
  (Reagents, Kits, Enzymes, Instruments
  Consumables, and Bioinformatics Tools),
  Technology (Histone Modification, DNA
  Methylation, and Others), Application (Oncology,
  Cardiovascular Diseases, and Others) End Users
  (Academic Research Institutes, Biotechnology
  Pharmaceutical Companies, and Contract Research
  Organization)
• The Epigenetics Market is projected to reach US
  2,611.57 million by 2025 from US 991.45 million
  in 2017 it is expected to grow at a CAGR of
  13.6 from 2017 to 2025.

3
Epigenetics Market Overview
Email sales_at_theinsightpartners.com

• The declining costs associated with different
  strategies and methods for sequencing supports to
  influence the scale and scope of almost all
  genomic research projects. The costs associated
  with DNA sequencing performed at the sequencing
  centers which is funded by the Institutes, has
  tracked by the National Human Genome Research
  Institute (NHGRI) for many years. This
  information has served as a key standard for
  establishing the DNA sequencing capacity and
  considering improvements in DNA sequencing
  technologies of the NHGRI Genome Sequencing
  Program (GSP). In the recent years, next
  generation sequencing price have declined
  substantially. For instance, first whole human
  genome sequencing cost over US3.7 billion in
  2000 and took 13 years for the completion.
  However, the costs for the same in recent years
  has reduced to US1,000 and the process requires
  less number of days. In 2000, cost for sequencing
  was US 3.7 billion, which dropped down to US 10
  million in 2006 and declined to US 5,000 in
  2012. Major market players such as Illumina and
  Roche have introduced breakthrough technologies
  that have enabled in the cost and time reduction
  in the sequencing. Owing to factors such as
  advances in the field of genomics, development in
  different methods and strategies for sequencing,
  there is a notable decline in the cost of
  sequencing, that upsurge the growth of the market.

4
Key Segment Market
Email sales_at_theinsightpartners.com

• Segment By Type-
• By Product (Reagents, Kits, Enzymes, Instruments
  Consumables, and Bioinformatics Tools)
• Technology (Histone Modification, DNA
  Methylation, and Others)
• Application (Oncology, Cardiovascular Diseases,
  and Others)
• End-User (Academic Research Institutes,
  Biotechnology Pharmaceutical Companies, and
  Contract Research Organization)

Download Sample Here
5
Epigenetics Market Value
Email sales_at_theinsightpartners.com

• CAGR of 13.6
• (2017 - 2025)

Download Sample
6
Company Profiles
Email sales_at_theinsightpartners.com

• Merck KGaA
• Thermo Fisher Scientific Inc.
• ABCAM Plc
• Agilent Technologies
• Active Motif
• Qiagen
• Bio-Rad Laboratories, Inc.
• Perkinelmer Inc.
• New England Biolabs (NEB)
• Illumina Inc.

Download Sample Here
7
By Geography
Email sales_at_theinsightpartners.com

• North America (the US, Canada, and Mexico)
• Europe (the UK, Germany, France, Italy, Spain,
  and the Rest of Europe)
• Asia Pacific (China, Japan, India, Australia,
  South Korea, and the Rest of Asia Pacific)
• Middle East Africa (the UAE, Saudi Arabia,
  South Africa, and the Rest of Middle East
  Africa)
• South Central America (Brazil, Argentina, and
  the Rest of South Central America).

8
THANKYOU!

• Phone  [phone]

• E-Mail sales_at_theinsightpartners.com